CONCERT PHARMACEUTICALS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Concert Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q3 2022.
  • Concert Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$28.9M, a 8.34% decline year-over-year.
  • Concert Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$126M, a 90.5% decline year-over-year.
  • Concert Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$80.1M, a 7.07% decline from 2020.
  • Concert Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$74.8M, a 4.35% increase from 2019.
  • Concert Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2019 was -$78.2M, a 39.5% decline from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$126M -$28.9M -$2.23M -8.34% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 -$124M -$23.5M -$29M -534% Apr 1, 2022 Jun 30, 2022 10-Q 2022-11-07
Q1 2022 -$95.1M -$37.7M -$15.1M -66.4% Jan 1, 2022 Mar 31, 2022 10-Q 2022-11-07
Q4 2021 -$80.1M -$36.1M -$13.7M -61.4% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-03
Q3 2021 -$66.3M -$26.7M -$7.77M -41.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$58.5M $5.43M +$18.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-07
Q1 2021 -$77M -$22.7M -$2.19M -10.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-07
Q4 2020 -$74.8M -$22.4M -$1.9M -9.29% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-25
Q3 2020 -$72.9M -$18.9M -$1.72M -10% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$71.1M -$13M +$5.68M +30.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$76.8M -$20.5M +$1.35M +6.18% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
Q4 2019 -$78.2M -$20.5M +$362K +1.74% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$78.5M -$17.2M +$202K +1.16% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$78.7M -$18.7M -$5.34M -40.1% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$73.4M -$21.8M -$17.4M -389% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$56M -$20.8M -$14.8M -244% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$41.2M -$17.4M -$145M -114% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 $104M -$13.3M -$298K -2.29% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 $105M -$4.46M +$8.87M +66.5% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 $95.6M -$6.07M +$5.98M +49.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 $89.7M $128M +$139M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$49.8M -$13M +$414K +3.08% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$50.2M -$13.3M +$547K +3.94% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$50.7M -$12M -$12.7M -1861% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$38M -$11.4M -$2.8M -32.8% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$35.2M -$13.4M -$54.5M -133% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 $19.3M -$13.9M -$4.88M -54.2% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 $24.2M $684K +$9.61M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 $14.6M -$8.55M -$722K -9.22% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 $15.3M $41M +$49M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 -$33.8M -$9M -$2.05M -29.5% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
Q4 2014 -$31.7M -$8.93M -$3.01M -50.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-01
Q3 2014 -$28.7M -$7.83M -$705K -9.89% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-01
Q2 2014 -$28M -$7.99M -$16.8M -191% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-01
Q1 2014 -$11.2M -$6.95M -$5.17M -291% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-01
Q4 2013 -$6.06M -$5.92M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-02
Q3 2013 -$7.13M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-02
Q2 2013 $8.77M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-02
Q1 2013 -$1.78M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.